Affymetrix Distributing Almac's Arrays for RNA Expression Profiling | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today announced it has reached a global distribution deal for Almac Group's Xcel array for research use in biomarker discovery targeting diseases such as cancer.

The array is built on Affy's GeneChip Human Genome U133 Plus 2.0 Array platform, optimized for RNA expression profiling from formalin-fixed, paraffin-embedded tissue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.